Filter
1005
Text search:
TB
epidemiological
data
Featured
107
289
Language
Document type
597
172
112
50
39
16
11
6
1
1
Countries
56
49
38
28
28
27
27
25
24
22
22
21
20
19
18
17
15
14
14
13
12
10
10
9
9
9
8
8
7
7
7
7
6
6
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
442
70
49
24
17
15
11
Toolboxes
258
64
56
38
27
25
23
17
17
17
17
16
13
13
11
10
10
8
6
6
3
2
2
2
1
BMC Infectious Diseases 2012, 12:352/1471-2334/12/352
Review
S Afr Med J 2014;104(3):174-177. DOI: 10.7196/SAMJ.7968
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
Harm reduction: evidence, impacts and challenges
-10-
Основная цель этого Руководства состоит в том, чтобы очертить рамки методов, используемых для оценки распространенности ВИЧ-инфекции среди больных туберкулезом и
...
WHO Regional Office for Africa
The Lancet Infectious Disease Volume 25, Issue 2e77-e85February 2025
The Journal of Infectious Diseases, jiy435, https://doi.org/10.1093/infdis/jiy435.
Many outbreaks reported high proportions of infected HWs. Similar HW infection rates and exposure risk factors in both past and recent EVD and MVD outbreaks emphasize the need to improve the implementation of approp
...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau
...
El objetivo de este artículo es analizar las condiciones de acceso a servicios de salud de las personas con tuberculosis en América
Latina y el Caribe (ALC), reflexionando desde la bioética sobre los aspectos de salud pública implicados. Se realizó una revisión
documental del contexto de la
...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma
...
A review of prospects for existing antibiotics ad new therapeutics
